Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Phillips

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|February 26, 1999
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphomaR P Gale, R E Park, R Dubois, et al.
Cancer|May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantationH M Lazarus, M R Gottfried, R H Herzig, et al.
Bone Marrow Transplantation|March 24, 1998
Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftmentO N Koç, S L Gerson, G L Phillips, et al.
Blood|April 1, 1991
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adultsG L Phillips, D E Reece, J D Shepherd, et al.
Leukemia|October 6, 2000
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cellsC T Jordan, D Upchurch, S J Szilvassy, et al.
British Journal of Haematology|January 31, 1998
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancerS H Bernstein, C J Eaves, R Herzig, et al.
Bone Marrow Transplantation|March 1, 1997
Treatment of leukemia with partially matched related bone marrow transplantationR K Munn, P J Henslee-Downey, E H Romond, et al.
Leukemia & Lymphoma|July 1, 1997
Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blastsB I Dalal, V Wu, M J Barnett, et al.
Bone Marrow Transplantation|May 13, 1998
Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factorsS R Jackson, M G Tweeddale, M J Barnett, et al.
Bone Marrow Transplantation|September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCTW I Bensinger, P S Becker, T A Gooley, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|February 26, 1999
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphomaR P Gale, R E Park, R Dubois, et al.
Cancer|May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantationH M Lazarus, M R Gottfried, R H Herzig, et al.
Bone Marrow Transplantation|March 24, 1998
Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftmentO N Koç, S L Gerson, G L Phillips, et al.
Blood|April 1, 1991
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adultsG L Phillips, D E Reece, J D Shepherd, et al.
Leukemia|October 6, 2000
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cellsC T Jordan, D Upchurch, S J Szilvassy, et al.
British Journal of Haematology|January 31, 1998
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancerS H Bernstein, C J Eaves, R Herzig, et al.
Bone Marrow Transplantation|March 1, 1997
Treatment of leukemia with partially matched related bone marrow transplantationR K Munn, P J Henslee-Downey, E H Romond, et al.
Leukemia & Lymphoma|July 1, 1997
Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blastsB I Dalal, V Wu, M J Barnett, et al.
Bone Marrow Transplantation|May 13, 1998
Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factorsS R Jackson, M G Tweeddale, M J Barnett, et al.
Bone Marrow Transplantation|September 15, 2015
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCTW I Bensinger, P S Becker, T A Gooley, et al.
Pageof 16